Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted psychotherapy in PTSD (Switzerland)
NCT00353938Phase 2Completed
- Sponsor
- Lykos Therapeutics
- Start
- Sep 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Full Dose MDMA with Active Placebo MDMA (2 arms). Primary endpoint: Clinician Administered PTSD Scale for DSM-IV. Started Sep 2006; status: completed.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00353938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353938.